MPM Asset Management Investors 2005 BVIII LLC insider trades: Somaxon Pharmaceuticals (SOMX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where MPM Asset Management Investors 2005 BVIII LLC reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 9, 2012 | SOMX | ↓ Sell | 2,295,791 | $0.30 | $694K | Indirect | Jul 10, 2012 (1d) |
| Jul 2, 2012 | SOMX | ↓ Sell | 178,558 | $0.29 | $52K | Indirect | Jul 5, 2012 (3d) |
| Jun 28, 2012 | SOMX | ↓ Sell | 19,500 | $0.29 | $6K | Indirect | Jul 2, 2012 (4d) |
| Jun 19, 2012 | SOMX | ↓ Sell | 12,000 | $0.29 | $3K | Indirect | Jun 21, 2012 (2d) |
| Jun 15, 2012 | SOMX | ↓ Sell | 1,450 | $0.29 | $420 | Indirect | Jun 19, 2012 (4d) |
| Jun 6, 2012 | SOMX | ↓ Sell | 37,955 | $0.29 | $11K | Indirect | Jun 7, 2012 (1d) |
| May 31, 2012 | SOMX | ↓ Sell | 811,422 | $0.30 | $244K | Indirect | Jun 4, 2012 (4d) |
| Nov 9, 2009 | PARD | ↓ Sell | 494,962 | $8.19 | $4.1M | Indirect | Nov 9, 2009 (0d) |
| Jul 8, 2009 | SOMX | ↑ Buy | 1,276,593 | $1.05 | $1.3M | Indirect | Jul 9, 2009 (1d) |
| May 8, 2007 | SOMX | ↓ Sell10b5-1 | 72,900 | $18.23 | $1.3M | Indirect | May 10, 2007 (2d) |
| May 4, 2007 | SOMX | ↓ Sell10b5-1 | 3,800 | $18.00 | $68K | Indirect | May 8, 2007 (4d) |
| May 2, 2007 | SOMX | ↓ Sell10b5-1 | 32,600 | $18.07 | $589K | Indirect | May 3, 2007 (1d) |
| Apr 30, 2007 | PARD | ↑ Buy | 900,000 | $6.33 | $5.7M | Indirect | May 1, 2007 (1d) |
| Apr 30, 2007 | SOMX | ↓ Sell10b5-1 | 62,600 | $18.07 | $1.1M | Indirect | May 1, 2007 (1d) |
| Dec 20, 2005 | SOMX | ↑ Buy | 318,000 | $11.00 | $3.5M | Indirect | Dec 22, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About MPM Asset Management Investors 2005 BVIII LLC's insider trades
MPM Asset Management Investors 2005 BVIII LLC is a 10% owner of Somaxon Pharmaceuticals (SOMX). Since Dec 20, 2005, it has reported 3 open-market purchases worth $10.5M and 12 sales worth $8.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
4 sales (38% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Its filings also include conversions (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SOMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.